Coherus Will Launch US Lucentis Biosimilar By 2021

Deal With Bioeq Pulls Forward Ranibizumab Launch By Two Years

 
• By Akriti Seth
  
Red_Numbers_2021
Coherus has struck a deal that will allow it to launch a biosimilar version of Lucentis by 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business